Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Conference
National Workers' Comp Conference 2017
The National Workers’ Compensation and Disability Conference & Expo (NWC&a
Workers' Comp
Podcast
Rigorous vs. Permissive Utilization Review: Beyond the ‘Rubber Stamp’
Mitchell
Conference
Mitchell 2018 mPower Conference
Join us for Mitchell’s annual customer gathering, the Mitchell 2018 mPower Conference.
Workers' Comp
Article
Communication is Key to Ending Disparity
A couple years ago, Genex surveyed our case managers to determine the
Risk & Insurance
In the News
Building Trust With Injured LGBTQ Employees
Workers' Comp
White Paper
Value-Based Contracting
Defining “Value-Based Contracting” Requires More Than a Few Words In conversations with clients and providers during the past six months